tru Independence LLC cut its holdings in The Allstate Co. (NYSE:ALL - Free Report) by 24.9% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 33,645 shares of the insurance provider's stock after selling 11,156 shares during the period. Allstate comprises 1.9% of tru Independence LLC's holdings, making the stock its 17th largest holding. tru Independence LLC's holdings in Allstate were worth $6,381,000 as of its most recent SEC filing.
Other hedge funds have also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC raised its holdings in Allstate by 18.7% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider's stock valued at $569,114,000 after buying an additional 472,040 shares during the period. Raymond James & Associates increased its position in Allstate by 10.6% during the third quarter. Raymond James & Associates now owns 1,517,800 shares of the insurance provider's stock valued at $287,851,000 after acquiring an additional 145,986 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Allstate by 3.4% in the second quarter. Dimensional Fund Advisors LP now owns 1,437,688 shares of the insurance provider's stock valued at $229,545,000 after acquiring an additional 47,038 shares during the period. Pathway Financial Advisers LLC lifted its holdings in shares of Allstate by 18,472.5% in the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider's stock worth $199,642,000 after acquiring an additional 1,047,019 shares during the last quarter. Finally, Hsbc Holdings PLC boosted its stake in shares of Allstate by 3.3% during the 2nd quarter. Hsbc Holdings PLC now owns 1,007,953 shares of the insurance provider's stock worth $160,948,000 after purchasing an additional 31,789 shares during the period. 76.47% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Allstate
In other news, EVP Elizabeth Brady sold 49,481 shares of the business's stock in a transaction on Friday, August 16th. The shares were sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the sale, the executive vice president now directly owns 19,163 shares of the company's stock, valued at $3,431,901.67. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Allstate news, insider John E. Dugenske sold 36,367 shares of the firm's stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares of the company's stock, valued at approximately $5,236,922.32. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Elizabeth Brady sold 49,481 shares of Allstate stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the sale, the executive vice president now owns 19,163 shares of the company's stock, valued at approximately $3,431,901.67. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 192,530 shares of company stock worth $34,967,665. 1.80% of the stock is owned by corporate insiders.
Allstate Stock Up 0.3 %
Shares of Allstate stock traded up $0.62 during trading on Monday, reaching $197.52. The company's stock had a trading volume of 1,251,868 shares, compared to its average volume of 1,556,289. The company has a 50-day simple moving average of $189.09 and a two-hundred day simple moving average of $175.87. The Allstate Co. has a 1-year low of $129.17 and a 1-year high of $201.00. The company has a market cap of $52.30 billion, a price-to-earnings ratio of 12.79, a P/E/G ratio of 1.83 and a beta of 0.48. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43.
Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, topping analysts' consensus estimates of $2.20 by $1.71. The business had revenue of $16.63 billion for the quarter, compared to analyst estimates of $14.57 billion. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The company's revenue was up 14.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.81 earnings per share. As a group, equities analysts forecast that The Allstate Co. will post 15.32 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several analysts have issued reports on ALL shares. TD Cowen raised their price objective on shares of Allstate from $193.00 to $224.00 and gave the stock a "buy" rating in a research note on Tuesday, September 3rd. Bank of America boosted their price objective on Allstate from $216.00 to $233.00 and gave the company a "buy" rating in a report on Friday, October 18th. BMO Capital Markets increased their target price on Allstate from $205.00 to $214.00 and gave the stock an "outperform" rating in a research note on Friday, October 18th. Jefferies Financial Group boosted their price objective on shares of Allstate from $231.00 to $267.00 and gave the company a "buy" rating in a research report on Friday. Finally, Wells Fargo & Company raised their price objective on Allstate from $175.00 to $186.00 and gave the stock an "equal weight" rating in a report on Tuesday, November 5th. One analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, Allstate presently has an average rating of "Moderate Buy" and a consensus target price of $212.56.
Read Our Latest Stock Report on ALL
Allstate Company Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report